Abstract We, the Editors and Publisher of Drug Delivery have retracted the following article:
Sultan Alshehri, Syed Sarim Imam, Afzal Hussain, Mohammad A. Altamimi, Nabil K …

An industrially feasible approach to overcome the solubility and bioavailability limitations of
poorly soluble active pharmaceutical ingredients is the development of amorphous solid …

Luteolin (LT) is a poorly soluble bioactive compound that suffered bioavailability problems
after oral administration. Hence, the aim of the proposed research work was to formulate and …

Material suitability needs to be considered for the 3D printing of solid oral dosage forms
(SODFs). This work aims to assess the suitability of a CO2 laser (λ= 10.6 μm) for selective …

When developing an amorphous solid dispersion (ASD), a prudent choice of polymer is
critical to several aspects of ASD performance including: processability, solid state stability …

Co-amorphous systems have been proven to be a promising strategy to address the poor
water solubility of poorly water-soluble drugs. Generally, the initial dissolution behaviors …

PROteolysis TArgeting Chimaeras (PROTACs) offer new opportunities in modern medicine
by targeting proteins that are undruggable to classic inhibitors. However, due to their …

Fisetin (FIS), a senolytic flavonoid, mitigates age-related neuroprotective changes. An
amorphous FIS dispersion with a co-carrier was prepared using supercritical fluid extraction …

The low bioaccessibility of hesperetin and piperine hampers their application as therapeutic
agents. Piperine has the ability to improve the bioavailability of many compounds when co …

Binary polymeric amorphous carvedilol solid dispersions were prepared using solvent
method by varying solvent type, polymer type and carvedilol to polymer ratio in order to …